Inder S. Anand

55.0k total citations · 11 hit papers
420 papers, 23.2k citations indexed

About

Inder S. Anand is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Inder S. Anand has authored 420 papers receiving a total of 23.2k indexed citations (citations by other indexed papers that have themselves been cited), including 327 papers in Cardiology and Cardiovascular Medicine, 48 papers in Endocrinology, Diabetes and Metabolism and 47 papers in Surgery. Recurrent topics in Inder S. Anand's work include Heart Failure Treatment and Management (221 papers), Cardiovascular Function and Risk Factors (159 papers) and Cardiac pacing and defibrillation studies (72 papers). Inder S. Anand is often cited by papers focused on Heart Failure Treatment and Management (221 papers), Cardiovascular Function and Risk Factors (159 papers) and Cardiac pacing and defibrillation studies (72 papers). Inder S. Anand collaborates with scholars based in United States, United Kingdom and India. Inder S. Anand's co-authors include Jay N. Cohn, Aldo P. Maggioni, Roberto Latini, John J.V. McMurray, Thomas S. Rector, Scott D. Solomon, Bertram Pitt, Michael R. Zile, Peter E. Carson and Serge Masson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Inder S. Anand

406 papers receiving 22.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Seattle Heart Failure Model

2006 1.5k citations Inder S. Anand, Aldo P. Maggioni et al. Circulation profile →
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

2003 661 citations Inder S. Anand, Roberto Latini et al. Circulation profile →
Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

2007 549 citations Roberto Latini, Serge Masson et al. Circulation profile →
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

2017 404 citations Sheryl L. Chow, Alan S. Maisel et al. Circulation profile →
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

2013 400 citations Karl Swedberg, James B. Young et al. profile →
Anemia and Iron Deficiency in Heart Failure

2018 378 citations Inder S. Anand et al. Circulation profile →
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

2015 335 citations Scott D. Solomon, Brian Claggett et al. profile →
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone

2015 329 citations Amil M. Shah, Brian Claggett et al. Circulation profile →
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

2020 266 citations Milton Packer, Gerasimos Filippatos et al. Circulation profile →
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

2021 226 citations Milton Packer, Faı̈ez Zannad et al. Circulation profile →
A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction

2021 209 citations Dirk J. van Veldhuisen, Mark Richards et al. JACC Heart Failure profile →

Peers

Countries citing papers authored by Inder S. Anand

Since Specialization

Citations

This map shows the geographic impact of Inder S. Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inder S. Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inder S. Anand more than expected).

Fields of papers citing papers by Inder S. Anand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inder S. Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inder S. Anand. The network helps show where Inder S. Anand may publish in the future.

Co-authorship network of co-authors of Inder S. Anand

This figure shows the co-authorship network connecting the top 25 collaborators of Inder S. Anand. A scholar is included among the top collaborators of Inder S. Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inder S. Anand. Inder S. Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF 2025 ·JACC Heart Failure ·Toru Kondo, Pardeep S. Jhund, Inder S. Anand, Brian Claggett, Akshay S. Desai, Kieran F. Docherty, (unknown), Martin Lefkowitz, Aldo P. Maggioni, Felipe A. Martínez, Margaret M. Redfield, Jean L. Rouleau, Dirk Jan van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Scott Solomon, John J.V. McMurray	2
2	Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction 2025 ·JACC Heart Failure ·Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt, Tor Biering‐Sørensen, Akshay S. Desai, Eldrin F. Lewis, Pardeep S. Jhund, Finnian R. Mc Causland, Inder S. Anand, Marc A. Pfeffer, Bertram Pitt, (unknown), Michael R. Zile, John J.V. McMurray, Scott Solomon, Muthiah Vaduganathan	2
3	Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction 2024 ·JACC Heart Failure ·Brendon L. Neuen, Muthiah Vaduganathan, Brian Claggett, Iris E. Beldhuis, Peder L. Myhre, Akshay S. Desai, Hicham Skali, Finnian R. Mc Causland, Martina M. McGrath, Inder S. Anand, Michael R. Zile, Marc A. Pfeffer, John J.V. McMurray, Scott D. Solomon	8
4	Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results 2024 ·Journal of Cardiac Failure ·Marvin A. Konstam, James E. Udelson, Douglas L. Mann, Javed Butler, Jeffrey L. Ardell, Gaetano Maria De Ferrari, Helmut Klein, Gerasimos Filippatos, Marco Metra, Inder S. Anand, Nicole Close, (unknown), Bruce H. KenKnight, Lorenzo A. DiCarlo, (unknown), (unknown), John D. Parker, John R. Teerlink	2
5	Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan 2021 ·Circulation Heart Failure ·Luís Eduardo Paim Rohde, Brian Claggett, Emil Wolsk, Milton Packer, Michael R. Zile, Karl Swedberg, Jean L. Rouleau, Marc A. Pfeffer, Akshay S. Desai, Lars H. Lund, Lars Køber, Inder S. Anand, Béla Merkely, Michele Senni, Victor Shi, Adel R. Rizkala, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon	14
6	Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF 2021 ·Journal of the American Heart Association ·Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin Lefkowitz, Michael R. Zile, Dirk J. van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo P. Maggioni, Michele Senni, Brian Claggett, Scott D. Solomon, John J.V. McMurray	28
7	Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction 2018 ·Circulation Heart Failure ·Senthil Selvaraj, Brian Claggett, Sanjiv J. Shah, Inder S. Anand, Jean L. Rouleau, Eileen O’Meara, Akshay S. Desai, Eldrin F. Lewis, Bertram Pitt, Nancy K. Sweitzer, James C. Fang, Marc A. Pfeffer, Scott D. Solomon	52
8	Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association breakdown → 2017 ·Circulation ·Sheryl L. Chow, Alan S. Maisel, Inder S. Anand, Biykem Bozkurt, Rudolf A. de Boer, G. Michael Felker, Gregg C. Fonarow, Barry Greenberg, James L. Januzzi, Michael S. Kiernan, Peter P. Liu, Thomas J. Wang, Clyde W. Yancy, Michael R. Zile	404
9	Increased Risk of Stroke with Darbepoetin Alfa in Anaemic Heart Failure Patients with Diabetes and Chronic Kidney Disease 2015 ·European Journal of Heart Failure ·Natalie A. Bello, Eldrin F. Lewis, Akshay S. Desai, Inder S. Anand, Henry Krum, John J.V. McMurray, Kurt Olson, Scott D. Solomon, Karl Swedberg, Dirk J. van Veldhuisen, James B. Young, Marc A. Pfeffer	34
10	Changes in N-Terminal Pro-B-Type Natriuretic Peptide Levels and Outcomes in Heart Failure with Preserved Ejection Fraction: An Analysis of the I-Preserve Study 2015 ·European Journal of Heart Failure ·Pardeep S. Jhund, Inder S. Anand, Michel Komajda, Brian Claggett, Robert S. McKelvie, Michael R. Zile, Peter E. Carson, John J.V. McMurray	53
11	Comparison of Outcomes After Hospitalization for Worsening Heart Failure, Myocardial Infarction, and Stroke in Patients with Heart Failure and Reduced and Preserved Ejection Fraction 2014 ·European Journal of Heart Failure ·Søren Lund Kristensen, Pardeep S. Jhund, Lars Køber, David Preiss, John Kjekshus, Robert S. McKelvie, Michael R. Zile, Inder S. Anand, John Wikstrand, Hans Wedel, Michel Komajda, Peter E. Carson, John G.F. Cleland, John J.V. McMurray	37
12	Calculated Plasma Volume Status and Prognosis in Chronic Heart Failure 2014 ·European Journal of Heart Failure ·Hua Ling, Julia Flint, Morten Damgaard, (unknown), Adrian S. H. Cheng, Suneil Aggarwal, Shanti Velmurugan, (unknown), Mohammed Rashid, Swan Kang, (unknown), Susanne Weißert, Caroline Coats, Martín Thomas, Michael A. Kuskowski, Jay N. Cohn, Simon Woldman, Inder S. Anand, Darlington O. Okonko	101
13	A Prediction Model for Sudden Cardiac Death in Patients with Heart Failure and Preserved Ejection Fraction 2014 ·European Journal of Heart Failure ·Selçuk Adabağ, Thomas S. Rector, Inder S. Anand, John J.V. McMurray, Michael R. Zile, Michel Komajda, Robert S. McKelvie, Barry M. Massie, Peter E. Carson	67
14	Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction 2013 ·Circulation Heart Failure ·Amil M. Shah, Sanjiv J. Shah, Inder S. Anand, Nancy K. Sweitzer, Eileen O’Meara, John F. Heitner, George Sopko, Guichu Li, Susan F. Assmann, Sonja M. McKinlay, Bertram Pitt, Marc A. Pfeffer, Scott D. Solomon	327
15	Baseline Characteristics of Patients in the Reduction of Events with Darbepoetin Alfa in Heart Failure Trial (RED-HF) 2013 ·European Journal of Heart Failure ·John J.V. McMurray, Inder S. Anand, Rafael Díaz, Aldo P. Maggioni, Christopher M. O’Connor, Marc A. Pfeffer, Scott D. Solomon, Michał Tendera, Dirk J. van Veldhuisen, Moetaz Albizem, Sunfa Cheng, Debra Scarlata, Karl Swedberg, James B. Young	23
16	Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) Registry 2013 ·European Journal of Heart Failure ·Carolyn S.P. Lam, Inder S. Anand, Shu Zhang, Wataru Shimizu, Calambur Narasimhan, Sang Weon Park, Cheuk‐Man Yu, Tachapong Ngarmukos, Razali Omar, Eugene B. Reyes, Bambang Budi Siswanto, Lieng Hsi Ling, Mark Richards	67
17	Baseline and Serial Measurements of Galectin-3 in Patients with Heart Failure: Relationship to Prognosis and Effect of Treatment with Valsartan in the Val-HeFT 2013 ·European Journal of Heart Failure ·Inder S. Anand, Thomas S. Rector, Michael A. Kuskowski, Aram Adourian, Pieter Muntendam, Jay N. Cohn	124
18	Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure 2011 ·Circulation ·Serge Masson, Inder S. Anand, Chiara Favero, Simona Barlera, Tarcisio Vago, Federico Bertocchi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, Jay N. Cohn, Roberto Latini	168
19	Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction 2010 ·Circulation ·Michael R. Zile, William H. Gaasch, Inder S. Anand, Markus Haass, William C. Little, Alan B. Miller, José López‐Sendón, John R. Teerlink, Michel White, John J.V. McMurray, Michel Komajda, Robert S. McKelvie, Agata Ptaszynska, Scott Hetzel, Barry M. Massie, Peter E. Carson	252
20	Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure 2006 ·Circulation ·JoAnn Lindenfeld, Arthur M. Feldman, Leslie A. Saxon, John Boehmer, Peter E. Carson, Jalal K. Ghali, Inder S. Anand, (unknown), Jonathan S. Steinberg, Brian E. Jaski, Teresa DeMarco, David Mann, Patrick Yong, Elizabeth Galle, Fred Ecklund, Michael R. Bristow	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact